ADP vs EDIT · P/E 20, rev $21.95B vs rev $32.3M
Automatic Data Processing Inc (ADP) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Automatic Data Processing Inc (ADP) is a software - application company listed on NASDAQ.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported ADP revenue for 2026-06-30 was $21.95B. Net income was $4.41B. Revenue was up 6.7% from 2025-06-30 to 2026-06-30. ADP currently screens at market cap $87.45B and trailing P/E 20.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
ADP currently screens at market cap $87.45B and trailing P/E 20.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the ADP and EDIT stock pages for the full models.
Not investment advice.